PPARGC1A and type 2 diabetes mellitus: It has been reported that the expression levels of PPARGC1A, as well as its downstream target genes was decreased in skeletal muscle of the elderlies and that mRNA levels were decreased in various atrophic states, such as denervation, reduced loading, and type 2 diabetes mellitus [39].